Better Prognosis by early Salvage Radiotherapy (PSA <0.2 ng/ml) in PSA-Progression after Prostate Cancer Surgery

被引：0
|
作者：
Thamm, R. [1 ]
Bartkowiak, D. [1 ]
Bottke, D. [2 ]
Siegmann, A. [3 ]
Boehmer, D. [3 ]
Budach, V [3 ]
Wiegel, T. [1 ]
机构：
[1] Univ Klinikum Ulm, Klin Strahlentherapie & Radioonkol, Ulm, Germany
[2] Klinikum Esslingen, Klin Strahlentherapie & Radioonkol, Esslingen, Germany
[3] Charite Univ Med Berlin, Klin Radioonkol & Strahlentherapie, CBF, Berlin, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2016年 / 192卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V16-1
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [21] The role for bone scans in men with high grade prostate cancer and PSA < 20 ng/ml
    Maislos, SD
    Grob, BM
    Terranova, S
    Macchia, R
    JOURNAL OF UROLOGY, 2002, 167 (04): : 224 - 225
  • [22] 18F-choline PET/CT for distant metastases at early stage of prostate cancer recurrence (PSA< 2 ng/ml), when local salvage radiotherapy is intended
    Cimitan, M.
    Bagatin, E.
    Bortolus, R.
    Canzonieri, V.
    Morassut, S.
    Borsatti, E.
    Trovo, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S157 - S157
  • [23] Diagnostic utility of total PSA, free PSA and PSA density at total serum PSA levels below 4 ng/ml compared to total serum PSA levels between 4.1 and 10.0 ng/ml in an early prostate cancer detection programme
    Berger, A
    Pelzer, A
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    Horninger, W
    JOURNAL OF UROLOGY, 2003, 169 (04): : 277 - 277
  • [24] Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level < 5 ng/ml
    Rioja Zuazu, Jorge
    Rodriguez, Macarena
    Rincon Mayans, Anibal
    Saiz Sansi, Abel
    Zudaire Bergera, Juan Javier
    Martinez-Monge, Rafael
    Angel Richter, Jose
    Berian Polo, Jose Maria
    ACTAS UROLOGICAS ESPANOLAS, 2009, 33 (08): : 844 - 852
  • [25] The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL
    Stephan, C
    Stroebel, G
    Heinau, M
    Lenz, A
    Roemer, A
    Lein, M
    Schnorr, D
    Loening, SA
    Jung, K
    CANCER, 2005, 104 (05) : 993 - 1003
  • [26] Complexed PSA for early detection of prostate cancer in men with serum PSA values of 2-4 ng/mL.
    Cheli, CD
    Horninger, W
    Babaian, R
    Fritsche, H
    Taneja, S
    Lepor, H
    Sokoll, L
    Chan, D
    Childs, S
    CLINICAL CHEMISTRY, 2002, 48 (06) : A15 - A15
  • [27] AGGRESSIVE PROSTATE CANCER IN VETERANS WITH A PRIOR PSA OF ≤1.0 NG/ML
    Ryan, Stephen
    Bryant, Alex
    Patel, Sunil
    Hamilton, Zachary
    Rose, Brent
    Kane, Christopher
    Murphy, James
    Kader, A. Karim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E440 - E441
  • [28] Proenzyme PSA for the early detection of prostate cancer in the 2.5-4.0 ng/ml total PSA range: Preliminary analysis
    Sokoll, LJ
    Chan, DW
    Mikolajczyk, SD
    Rittenhouse, HG
    Evans, CL
    Linton, HJ
    Mangold, LA
    Mohr, P
    Bartsch, G
    Klocker, H
    Horninger, W
    Partin, AW
    UROLOGY, 2003, 61 (02) : 274 - 276
  • [29] Complexed PSA and complexed/total PSA ratio for early detection of prostate cancer in men with serum PSA 2-4 ng/mL.
    Cheli, CD
    Ferreri, LF
    Chan, DW
    Sokoll, L
    Yeung, KK
    Allard, WJ
    Partin, AW
    Brawer, MK
    CLINICAL CHEMISTRY, 2000, 46 (06) : A157 - A157
  • [30] IS PSA VELOCITY USEFUL FOR PROSTATE CANCER DETECTION OR PROGNOSTICATION IN MEN WITH A PSA > 10 NG/ML?
    Loeb, Stacy
    Roehl, Kimberly A.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 811 - 811
12345